Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Summary
The primary objective for this study is to evaluate the efficacy of NBI-1117570 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults who warrant inpatient hospitalization.
Official title: A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117570 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-03
Completion Date
2027-08
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
NBI-1117570
Oral administration
Placebo
Oral administration